[
    [
        {
            "time": "",
            "original_text": "医药行业中国研发外包行业迎来高景气周期(系列二):基于12家CRO、CDMO企业的比较分析",
            "features": {
                "keywords": [
                    "医药行业",
                    "研发外包",
                    "高景气周期",
                    "CRO",
                    "CDMO"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "研发外包"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药行业中国研发外包行业迎来高景气周期(系列二):基于12家CRO、CDMO企业的比较分析",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        }
    ]
]